Denmark Announces Trial Program for Medical Cannabis

Denmark Announces Trial Program for Medical Cannabis

Flickr / Jacob Botter / CC BY 2.0

On Nov. 8, 2016, Denmark announced that it will launch a medical cannabis trial program in 2018, as reported by AFP.

“Patients with a number of selected diseases and symptoms that have previously been treated with relevant, approved drugs, can be prescribed medical cannabis at the individual doctor’s responsibility,” stated Denmark’s health ministry.

According to a ministry spokesman, approximately 500 patients will participate in the program’s launch, with the patient count increasing to 1,500 in 2021.

The Danish Medicines Agency has recommended that patients suffering from the following conditions be eligible for the program: paraplegia, multiple sclerosis, chronic pain and chemotherapy-induced nausea.

While multiple political parties want to legalize recreational cannabis in the country, Denmark’s three largest parties are opposed it—the Social Democrats, the anti-immigration Danish People’s Party and the ruling Venstre party.

The staff byline designates content that has been written by a staff writer of MJINews.

Related posts